News

Deal Announcements

Aratana Therapeutics Lands Venture Capital Debt

Monday, March 11, 2013 5:57:00 AM PDT | VentureDeal
   Kansas City, Missouri  --  Animal pharmaceutical company Aratana Therapeutics has secured $10 million in new venture capital debt funding.

Aratana acquires proprietary compounds from human pharmaceutical and biotech companies to develop medicines for companion animals, i.e., cats and dogs.

Square 1 Bank provided the financing, which the company said would be used to fund general corporate purposes.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1